Home/Filings/4/0001209191-23-010561
4//SEC Filing

Cooper Simon Peter 4

Accession 0001209191-23-010561

CIK 0001664710other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:15 PM ET

Size

5.5 KB

Accession

0001209191-23-010561

Insider Transaction Report

Form 4
Period: 2023-02-16
Cooper Simon Peter
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-02-16+40,00040,000 total
    Exercise: $54.38Exp: 2033-02-15Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option shall vest on February 16, 2024, and 6.25% of the shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Keros Therapeutics, Inc.

CIK 0001664710

Entity typeother

Related Parties

1
  • filerCIK 0001877225

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:15 PM ET
Size
5.5 KB